DEA Extends COVID-19 Telemedicine Controlled Substance Prescriptions
DEA indicates along with SAMHSA that it will review comments received in response to the March 2023 Proposed Rules, conduct a thorough evaluation of regulatory alternatives, and issue one or more final rules based on the March 2023 Proposed Rules prior to 11 November 2023
Source: natlawreview.com